COMMONS

Impact of EU regulation on UK life sciences further examined

19 April 2016

The Science and Technology Committee questions representatives from medical charities, the regulatory sector and Government on the impact of EU regulation on UK life sciences.

Witnesses

Tuesday 19 April 2016, Thatcher Room, Portcullis House

At 2.15pm

  • Emma Greenwood, Head of Policy Development, Cancer Research UK

At 2.45pm

  • Dr Ian Hudson, Chief Executive, Medicines and Healthcare products Regulatory Agency
  • Jonathan Mogford, Director of Policy, Medicines and Healthcare products Regulatory Agency
  • John Wilkinson, Director of Devices, Medicines and Healthcare products Regulatory Agency

At 3.15pm

  • George Freeman MP, Parliamentary Under-Secretary of State for Life Sciences, Department for Business, Innovation and Skills and the Department of Health

Further Information

Image: iStockphoto

More news on: Parliament, government and politics, Parliament, House of Commons news, Commons news, Committee news, Science and technology

Share this page